INOmax - direct healthcare professional communication (DHPC)

Nitric oxide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): INOmax (nitric oxide) - Difficulties in closing the cylinder valves after use: precautions for use when disconnecting the cylinders from pressure regulators

Dissemination date: 03/06/2021

Key facts

• Medicine name:
  INOmax
• Active substance:
  Nitric oxide
• Therapeutic area (MeSH):
  • Hypertension, Pulmonary
  • Respiratory Insufficiency
• Procedure number:
  EMEA/H/C/000337
• Regulatory outcome:
  Maintenance
• DHPC type:
  Quality defect
• Human ATC codes:
  R07AX
• Dissemination date:
  03/06/2021